Henderson D J, Naya I, Bundick R V, Smith G M, Schmidt J A
Dept. of Biochemistry, Fisons Pharmaceuticals plc, Loughborough, Leicestershire, U.K.
Immunology. 1991 Jul;73(3):316-21.
The immunosuppressive compounds FK-506, cyclosporin A (CsA) and rapamycin inhibit both the human and mouse mixed lymphocyte reactions (MLR) with IC50s of 2-5 x 10(-10) M for FK-506 and rapamycin and 10(-8) M for CsA. FK-506 and CsA were also potent inhibitors of A23187/PMA-stimulated IL-2 production by Jurkat and HuT-78 cells but had no effect on the response of mouse CTLL cells to IL-2. IC50 values for inhibition of IL-2 production closely matched those for inhibition of the MLR and both drugs were active only during the first 4-6 hr following stimulation. In contrast, rapamycin was a poor inhibitor of IL-2 production, although it inhibited cellular responses to IL-2. The IC50 values for these two activities indicated that neither alone accounted for rapamycin inhibition of the MLR. FK-506 and CsA affected IL-2 gene transcription in Jurkat cells by the same mechanism. Both inhibited the appearance of the transcription factor, NFAT, whereas rapamycin did not. The appearance of another transcription factor, NFK beta, was unaffected by all three drugs. The effects of FK-506 and CsA on IL-2 gene expression, therefore, are similar even though the two drugs act through distinct cytosolic receptors.
免疫抑制化合物FK-506、环孢素A(CsA)和雷帕霉素均可抑制人和小鼠的混合淋巴细胞反应(MLR),FK-506和雷帕霉素的IC50为2-5×10(-10)M,CsA的IC50为10(-8)M。FK-506和CsA也是Jurkat和HuT-78细胞中A23187/PMA刺激的IL-2产生的有效抑制剂,但对小鼠CTLL细胞对IL-2的反应没有影响。抑制IL-2产生的IC50值与抑制MLR的IC50值密切匹配,且两种药物仅在刺激后的前4-6小时具有活性。相比之下,雷帕霉素虽然能抑制细胞对IL-2的反应,但对IL-2产生的抑制作用较弱。这两种活性的IC50值表明,单独一种都不能解释雷帕霉素对MLR的抑制作用。FK-506和CsA通过相同机制影响Jurkat细胞中的IL-2基因转录。两者均抑制转录因子NFAT的出现,而雷帕霉素则没有。另一种转录因子NFKβ的出现不受这三种药物的影响。因此,尽管FK-506和CsA通过不同的胞质受体发挥作用,但它们对IL-2基因表达的影响是相似的。